Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 1
1996 1
1997 1
1998 1
1999 3
2004 1
2005 1
2006 2
2007 1
2008 2
2010 1
2012 1
2016 2
2017 1
2020 1
2021 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Transfusion-related acute lung injury.
Sheppard CA, Lögdberg LE, Zimring JC, Hillyer CD. Sheppard CA, et al. Hematol Oncol Clin North Am. 2007 Feb;21(1):163-76. doi: 10.1016/j.hoc.2006.11.011. Hematol Oncol Clin North Am. 2007. PMID: 17258125 Free article. Review.
Convalescent Plasma for Preventing Critical Illness in COVID-19: a Phase 2 Trial and Immune Profile.
Sturek JM, Thomas TA, Gorham JD, Sheppard CA, Raymond AH, Petros De Guex K, Harrington WB, Barros AJ, Madden GR, Alkabab YM, Lu DY, Liu Q, Poulter MD, Mathers AJ, Thakur A, Schalk DL, Kubicka EM, Lum LG, Heysell SK. Sturek JM, et al. Among authors: sheppard ca. Microbiol Spectr. 2022 Feb 23;10(1):e0256021. doi: 10.1128/spectrum.02560-21. Epub 2022 Feb 23. Microbiol Spectr. 2022. PMID: 35196802 Free PMC article. Clinical Trial.
Paraprotein interference in automated chemistry analyzers.
Sheppard CA, Allen RC, Austin GE, Young AN, Ribeiro MA, Fantz CR. Sheppard CA, et al. Clin Chem. 2005 Jun;51(6):1077-8. doi: 10.1373/clinchem.2004.045740. Clin Chem. 2005. PMID: 15914801 No abstract available.
Convalescent plasma for preventing critical illness in COVID-19: A phase 2 trial and immune profile.
Sturek JM, Thomas TA, Gorham JD, Sheppard CA, Raymond AE, Guex KP, Harrington WB, Barros AJ, Madden GR, Alkabab YM, Lu D, Liu Q, Poulter MD, Mathers AJ, Thakur A, Kubicka EM, Lum LG, Heysell SK. Sturek JM, et al. Among authors: sheppard ca. medRxiv [Preprint]. 2021 Feb 19:2021.02.16.21251849. doi: 10.1101/2021.02.16.21251849. medRxiv. 2021. PMID: 33619508 Free PMC article. Updated. Preprint.
Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients.
Giovannoni G, Cohen JA, Coles AJ, Hartung HP, Havrdova E, Selmaj KW, Margolin DH, Lake SL, Kaup SM, Panzara MA, Compston DA; CARE-MS II Investigators. Giovannoni G, et al. Neurology. 2016 Nov 8;87(19):1985-1992. doi: 10.1212/WNL.0000000000003319. Epub 2016 Oct 12. Neurology. 2016. PMID: 27733571 Free PMC article. Clinical Trial.
24 results